Location: Oxford Science Park (Hybrid – 2–3 days on site)
At Oxford Nanopore Technologies, we are redefining what’s possible in molecular sensing. Our pioneering nanopore-based technology is transforming scientific discovery and healthcare by enabling real-time, accessible DNA and RNA sequencing across research, clinical, and applied markets globally. As a fast-growing, innovative organisation with an international footprint, we are building scalable finance capabilities to support the next stage of our growth journey.
We are looking for an experienced Accounting Hub Manager to lead a centralised finance team delivering accurate and timely financial reporting across multiple international legal entities.
Reporting to the Director of Group Financial Reporting, this role sits at the heart of our finance transformation. You will own the integrity of month-end close, balance sheet control, statutory compliance, and audit engagement across a growing global portfolio, while also leading a small team within the Accounting Hub.
This is a unique opportunity to combine operational excellence with transformation. You will play a key role in stabilising and standardising processes as activities transition into the Accounting Hub, while driving future improvements in efficiency, controls, and scalability.
Key ResponsibilitiesPlease note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability, or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-LH1
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
